Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
申请人:Angell Martyn Richard
公开号:US20050065195A1
公开(公告)日:2005-03-24
Compounds of formula (I), wherein R3 is the group; or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
Evolution of a Novel Series of [(N,N-Dimethylamino)propyl]- and Piperazinylbenzanilides as the First Selective 5-HT1D Antagonists
作者:John W. Clitherow、David I. C. Scopes、Malcolm Skingle、Christopher C. Jordan、Wasyl Feniuk、Ian B. Campbell、Malcolm C. Carter、Eric W. Collington、Helen E. Connor